A pilot study evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon.

Journal article

Open access

Peer reviewed

Sasha N. Jenkins, Kimberly M. Neyman, Emir Veledar and Suephy C. Chen

Journal of the American Academy of Dermatology, Vol.69(5), pp.834-835

2013

Files and links (6)

url

https://lens.org/001-541-281-792-399View

url

https://www.jaad.org/article/S0190-9622(13)00662-2/fulltextView

url

https://pubmed.ncbi.nlm.nih.gov/24124825/View

url

https://www.ncbi.nlm.nih.gov/pubmed/24124825View

url

https://www.sciencedirect.com/science/article/pii/S0190962213006622View

7 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.106 Rheumatology; 1.106.1083 Systemic Sclerosis
Web Of Science research areas: Dermatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: A pilot study evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon.
Creators: Sasha N. Jenkins
Kimberly M. Neyman
Emir Veledar - Emory University
Suephy C. Chen
Publication Details: Journal of the American Academy of Dermatology, Vol.69(5), pp.834-835
Publisher: Elsevier BV; United States
Academic Unit: Miller School of Medicine; UMMG Department of Neurology
Resource Type: Journal article
Record Identifier: 991031996613302976